This discussion aims to raise awareness for the importance of molecular assessments and biomarker-guided treatment selection to help healthcare professionals make better informed and individualized treatment decisions for patients with NSCLC.
- Provider:Postgraduate Institute for Medicine
- Activity Link: https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/login/?utm_source=PIMpassport&utm_medium=external&utm_campaign=IlluminaRoche_webinar&utm_content=IlluminaRoche_webinar&utm_term=
- Start Date: 2024-06-28 05:00:00
- End Date: 2024-06-28 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- Commercial Support: Source: illumina - Amount: 63838.0 - Is Kind Support: False Source: Roche (Any division) - Amount: 125000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest